Device / Technology News

RSS

Covidien Solitaire FR Revascularization Device approved for investigational use

Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.

30 Jan 2012

MRI shows elevated BMI linked to greater extent and severity of degenerative disc disease

One of the largest studies to investigate lumbar spine disc degeneration found that adults who are overweight or obese were significantly more likely to have disc degeneration than those with a normal body mass index (BMI).

30 Jan 2012

USPTO allows Precision's claims relating to methods of cleaving DNA

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").

30 Jan 2012

Modern ultrasound for male contraception

The ideal male contraceptive would be inexpensive, reliable, and reversible. It would need to be long acting but have few side effects. New research published in BioMed Central's open access journal Reproductive Biology and Endocrinology used commercially available therapeutic ultrasound equipment to reduce sperm counts of male rats to levels which would result in infertility in humans.

30 Jan 2012

Helios Berlin Buch acquires Mobetron for Intra-Operative Electron Radiation Therapy

IntraOp Medical Corporation today announced that Helios Berlin Buch became the fourth German hospital and the nineteenth European hospital to purchase a Mobetron for Intra-Operative Electron Radiation Therapy (IOERT).

30 Jan 2012

Researcher have identified thirty one regions of genome associated with circulating metabolites

In a study to the genetic variance of human metabolism, researchers have identified thirty one regions of the genome that were associated with levels of circulating metabolites, i.e., small molecules that take part in various chemical reactions of human body.

30 Jan 2012

New mechanism of drug release using 3D superhydrophobic materials

According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.

30 Jan 2012

TiBREEZE breast implants included in explantation

The International Society for Aesthetic Plastic Surgery (ISAPS) has been officially informed by the German authorities at the BfArM Institute that the former company, GfE Medizintechnik GmbH in Germany, sold implants that were manufactured using PIP components.

30 Jan 2012

International Roadmap for TB Research outlines priorities

In this post in the PLoS "Speaking of Medicine" blog, guest blogger Christian Lienhardt, senior scientific adviser at the Stop TB Partnership and WHO, "discusses the International Roadmap for Tuberculosis (TB) Research, a framework outlining priority areas for investment in TB research."

30 Jan 2012

Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

A new company formed around Michigan State University nanotechnology promises to move speedy detection of deadly pathogens and toxins from the laboratory directly to the field.

30 Jan 2012

Medtronic signs exclusive distribution agreement with Miami Instruments

Medtronic, Inc. today announced that it has entered into an exclusive distribution agreement with Miami Instruments, LLC - a company focused on the design of innovative surgical instruments for minimally invasive cardiac surgery procedures - and has introduced the company's first two products in the U.S.

From Medtronic 30 Jan 2012

Pinpoint Genomics makes Pinpoint Dx Lung Assay available to clinicians, patients

Pinpoint Genomics, Inc. announced the publication of key data relating to its Pinpoint Dx Lung Assay in the journal The Lancet, and the availability of its Pinpoint Dx Lung Assay to clinicians and patients exclusively through the company's laboratory in Mountain View, CA.

30 Jan 2012

University of York scientists reveal how cholera attacks body

A team of biologists at the University of York has made an important advance in our understanding of the way cholera attacks the body.

30 Jan 2012

Study: Electronic health records can improve care, outcomes in patients with type 2 diabetes

Use of electronic health records shows promise for improving care and outcomes in patients with type 2 diabetes, but still has considerable room for improvement, according to a new study in the journal Health Services Research.

30 Jan 2012

Researchers develop new MRS technique to diagnose brain tumors

Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.

30 Jan 2012

Everist Genomics' CardioDefender Device to be featured at Wearable Technologies Conference

Everist Genomics announced today that Executive Vice Chairman Alex Charlton will speak about its breakthrough CardioDefender Device at the Wearable Technologies Conference, January 30, 2012, in Munich.

30 Jan 2012

Sorin opens ACCESS training center in Clamart

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today the opening of its Advanced Center for Continuous Education on Scientific Solutions - ACCESS - training center in Clamart.

27 Jan 2012

UH vision scientist hopes techniques lead to earlier diagnoses in glaucoma

A University of Houston (UH) vision scientist has received a $1.85 million grant from the National Institutes of Health (NIH) to investigate whether his techniques are more effective than others in understanding the earliest changes of glaucoma, which could lead to developing a way to earlier diagnose this potentially blinding disease.

27 Jan 2012

GenPath, BioReference Labs to introduce OnkoMatch solid tumor genotype test

BioReference Laboratories, Inc. and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts General Hospital (MGH) is introducing its groundbreaking solid tumor genotype test.

27 Jan 2012

CRT launches Acublate to develop HIFU cancer surgery device

Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.

27 Jan 2012